Market Research Logo

Malaysia Pharmaceuticals & Healthcare Q3 2018

Malaysia Pharmaceuticals & Healthcare Q3 2018

BMI View:

As further improvements are made to strengthen Malaysia’s fiscal position and business environment, investorconfidence in the economy will grow. The Malaysian Health Ministry has been taking an increasingly active role in developing thecountry's pharmaceuticals and healthcare sectors, namely through increasing healthcare access and pursuing policy changes toincrease the country's attractiveness to pharmaceutical companies. However, Malaysia’s designation as a 'Priority Foreign Country’ inPhRMA's 2018 submission highlights inadequate levels of intellectual property protection and mandatory medicine price disclosureas ongoing concerns for multinational drugmakers.


BMI Industry View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Divergent Regional Trends Will Shape Drugmaker Opportunities
Malaysia Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Chemical Company Of Malaysia
Kotra Pharma
Novartis
Ranbaxy Malaysia
Sanofi
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report